|
End-of-day quote
Shenzhen S.E.
17/08/2026
|
5-day change | 1st Jan Change | ||
| 37.83 CNY | -2.30% |
|
-0.42% | +12.76% |
| 07-27 | ApicHope Pharmaceutical Signs Clinical Trial Contract with Boji Medical Technology for Obesity Drug; Shares Rise 4% | MT |
| 07-24 | Declaration of Voting Results by ApicHope Pharmaceutical | CI |
| Market Cap | 16.97B 2.52B 2.17B 2.04B 1.86B 3.49B 241B 3.54B 23.9B 9.36B 121B 9.45B 9.25B 401B | P/E 2026 * |
32.6x | P/E 2027 * | -164x |
|---|---|---|---|---|---|
| Enterprise Value | 16.97B 2.52B 2.17B 2.04B 1.86B 3.49B 241B 3.54B 23.9B 9.36B 121B 9.45B 9.25B 401B | EV / Sales 2026 * |
15.7x | EV / Sales 2027 * | 13.5x |
| Free-Float |
31.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -2.30% | ||
| 1 week | -0.42% | ||
| Current month | +7.17% | ||
| 1 month | -9.61% | ||
| 3 months | -5.64% | ||
| 6 months | +13.64% | ||
| Current year | +12.76% |
| 1 week | 36.46 | 39.95 | |
| 1 month | 33.41 | 39.95 | |
| Current year | 29.31 | 45.88 | |
| 1 year | 29.31 | 76.88 | |
| 3 years | 12.74 | 81.48 | |
| 5 years | 12.74 | 81.48 | |
| 10 years | 7.58 | 81.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Han Xiong Li
CEO | Chief Executive Officer | 52 | 11/11/2015 |
Hui Xing Zhang
DFI | Director of Finance/CFO | 60 | 11/11/2015 |
Xiao Dong Liu
IRC | Investor Relations Contact | 38 | 31/12/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Han Xiong Li
CHM | Chairman | 52 | 11/11/2015 |
Han Dong Li
BRD | Director/Board Member | 58 | 11/11/2015 |
Liang Wen Huang
CHM | Chairman | 50 | 11/11/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/5/26 A | Buy | Director | 4,200 | 0.0010% | ||
| 11/24/25 A | Buy | Director | 7,000 | 0.0017% | ||
| 9/1/23 A | Buy | 20,000 | 0.0089% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.30% | -0.42% | -46.42% | +87.84% | 2.57B | ||
| -2.49% | -3.24% | +14.66% | +64.56% | 48.43B | ||
| -0.12% | -5.43% | +52.28% | +115.90% | 39.72B | ||
| -1.28% | -2.21% | -8.47% | +15.11% | 12.25B | ||
| -0.33% | +1.55% | +14.43% | +72.12% | 11.84B | ||
| -0.58% | -0.77% | +29.90% | +141.59% | 9.06B | ||
| 0.00% | +1.64% | +22.99% | +39.94% | 7.57B | ||
| -0.88% | +1.18% | +40.97% | -13.86% | 7.18B | ||
| +0.46% | +2.19% | +13.91% | +192.06% | 6.84B | ||
| +0.63% | -2.53% | -30.10% | +23.84% | 5.77B | ||
| Average | -0.69% | +0.43% | +10.42% | +73.91% | 15.12B | |
| Weighted average by Cap. | -1.03% | -1.17% | +22.45% | +78.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.08B 160M 138M 130M 118M 222M 15.32B 225M 1.52B 596M 7.67B 601M 588M 25.53B | 1.26B 187M 161M 151M 138M 259M 17.84B 262M 1.77B 694M 8.94B 701M 685M 29.74B |
| Net income | 526M 78.03M 67.36M 63.2M 57.56M 108M 7.46B 110M 741M 290M 3.74B 293M 287M 12.43B | -102M -15.13M -13.06M -12.25M -11.16M -20.99M -1.45B -21.28M -144M -56.3M -725M -56.81M -55.58M -2.41B |
| Net Debt | - | - |
Employees
1,294
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/08/26 | CN¥37.83 | -2.30% | 12,659,820 |
| 14/08/26 | CN¥38.72 | +0.60% | 14,473,434 |
| 13/08/26 | CN¥38.49 | +3.72% | 21,705,432 |
| 12/08/26 | CN¥37.11 | +0.08% | 10,038,222 |
| 11/08/26 | CN¥37.08 | -0.59% | 11,306,644 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300723 Stock
Select your edition
All financial news and data tailored to specific country editions
















